SENSEX NIFTY

Fda

Jul 24, 2014 at 12:57 | Source: Moneycontrol.com
After inspecting the companys active pharmaceutical ingredients (APIs) manufacturing unit at Raltam, US Food and Drug Administration (US FDA) has raised some concerns in Form 483. Hence the drug manufacturer will suspend shipments to the US markets till the issue is addressed.
Jul 22, 2014 at 09:35 | Source: Moneycontrol.com
The US Food and Drug Administration (US FDA) has approved the sterile facility (plant-II) and solid dosage facility (plant -III) located at Verna in the adjoining coastal state, a company release said.
Jul 21, 2014 at 22:18 | Source: PTI
The US Food and Drug Administration (US FDA) has approved the sterile facility (plant-II) and solid dosage facility (plant -III) located at Verna in the adjoining coastal state, a company release said.
Jul 14, 2014 at 10:45 | Source: Moneycontrol.com
Credit Suisse expects higher Food and Drug Administration (FDA) scrutiny during next inspection at Sun Pharmaceutical Industries' Halol facility.
Jul 11, 2014 at 11:32 | Source: PTI
According to a notification by the FDA, the recall of 26,530 units of 30-count bottles and 14,597 units of 90-count bottles is voluntarily initiated by the company through a letter to the regulator last month under 'Class-II' classification.
Jul 08, 2014 at 12:04 | Source: Moneycontrol.com
Glenmark Generics Inc., USA a subsidiary of Glenmark Generics has been granted final abbreviated new drug approval (ANDA) from the United States Food and Drug Administration (US FDA) for Telmisartan Tablets. Glenmark will commence distribution of the product immediately.
Jul 03, 2014 at 17:26 | Source: Reuters
The drug being recalled was manufactured by Sun Pharma's unit Caraco Pharmaceutical Laboratories Ltd at its plant in Gujarat, the FDA said in a post on its website.
Jun 27, 2014 at 11:15 | Source: Moneycontrol.com
Ranbaxys subsidiary Ohm Lab has received drug regulator US Food and Drug Administration's nod for generic version of Novartis blood pressure drug Diovan.
Jun 27, 2014 at 08:25 | Source: Reuters
Novartis lost its patent rights to Diovan in the United States at the end of 2012 but has avoided generic competition because of multiple quality control problems at Ranbaxy that prevented the company from exercising its right to become the first generic version of the drug on the market.
Jun 23, 2014 at 16:00 | Source: Reuters
The first round of technology may be limited, but eventually the companies could compete in a global blood-sugar tracking market worth over USD 12 billion by 2017, according to research firm GlobalData.
Messages on Fda »

BSE/NSE Announcer

Platinum Member

3550 Followers

Glenmark  

Glenmark Generics Inc., USA a subsidiary of Glenmark Generics has been granted final abbreviated new drug approval (ANDA) from the United States Food and Drug Administration (US FDA) for Telmisartan Tablets. Glenmark will commence distribution of the product immediately.

12.04 PM Jul 8th

BSE/NSE Announcer

Platinum Member

3550 Followers

Glenmark  

the United States Food and Drug Administration (US FDA) for Telmisartan Tablets. Glenmark will commence distribution of the product immediately.

12.04 PM Jul 8th

BSE/NSE Announcer

Platinum Member

3550 Followers

Shasun Pharma  

Shasun Pharmaceuticals Limited has informed the Exchange regarding a press release dated July 08, 2014, titled "Sucessful completion of US FDA and Mexican COFEPRIS inspection".

11.41 AM Jul 8th

BSE/NSE Announcer

Platinum Member

3550 Followers

Shasun Pharma  

Shasun Pharmaceuticals Ltd has informed BSE regarding a Press Release dated July 08, 2014, titled "Successful completion of US FDA and Mexican COFEPRIS inspection"

11.30 AM Jul 8th

hemal85

Silver Member

11 Followers

ITC  

how FDA (food & drug authority) is related with Mr. Modi?? & if u mean FDI....how will that make any difference to HUL or ITC??? kuchh bhi....

6.55 PM Jul 7th

teeyen

Silver Member

2 Followers

Natco Pharma  

Natco is an excellent stock with good prospects. However think of following before buying now. 1)Teva has filed a citizen petition before FDA which may delay copaxone generic approval by about 5-6 months 2) Teva has filed a petition in delhi high court for stopping production and export

6.38 PM Jul 7th

AlphaView

Gold Member

79 Followers

Granules India  

talking this even after discounting for risks such as FDA approvals et al.

6.13 PM Jul 7th

niftynewbie

Platinum Member

103 Followers

Ranbaxy Labs  

Spoiler could be sunpharma`s plants getting red-flagged by FDA ;)

5.10 PM Jul 7th

Sharon Bio Medicine  

Profit to fo up 3 fold! US FDA approval to come next qrtr!

3.22 PM Jul 7th

shivamparik
h

Platinum Member

30 Followers

ITC  

HUL doesnt deal in Cigarettes and FDA will be welcome by Mr. Modi. ITC may get benefits of Tourism ... HUL still wins out with a higher chance of UL bidding for complete or more control through buy out of shares. ITC will have issues with Govt. regulations in my opinion.

1.18 PM Jul 7th

News across the web »
Jul 25, 2014 at 08:12 | Source: Calcutta Telegraph News
Jul 22, 2014 at 22:00 | Source: VC Circle
Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.